Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,300 papers from all fields of science
Search
Sign In
Create Free Account
Non-Resectable Hepatoblastoma
Known as:
Hepatoblastoma, Nonresectable
, Unresectable Hepatoblastoma
Hepatoblastoma not amenable to surgical removal.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
19 relations
Anemia
Anorexia
Bile Ducts, Extrahepatic
CTNNB1 gene
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Pancreatic Cancer: a Split Tipe Therapy Idea
E. Alksnis
2019
Corpus ID: 207928235
Due to number of biochemical, physiological and anatomical reasons pancreatic cancer remain fast type killer. Solution could come…
Expand
Review
2017
Review
2017
Liver Transplantation for Unresectable Disease
P. Line
,
M. Hagness
,
J. Solheim
,
A. Foss
,
S. Dueland
2017
Corpus ID: 79555535
Surgical resection is the only curative modality for colorectal liver metastases (CLM), and 5-year overall survival after…
Expand
Review
2012
Review
2012
Treatment options for unresectable neuroendocrine liver metastases
B. J. John
,
B. Davidson
Expert Review of Gastroenterology & Hepatology
2012
Corpus ID: 26594259
Hepatic metastases develop in 85% of patients with gastroenteropancreatic neuroendocrine tumors. Radical surgery, which involves…
Expand
2011
2011
Photodynamic Therapy in Nonresectable Cholangiocarinoma—Is It Worth It?: 140
Jaydeep Bhat
,
F. Habr
2011
Corpus ID: 199045496
Review
2010
Review
2010
Current Opinion on Optimal Treatment Choices in First-line Therapy for Advanced or Metastatic Colorectal Cancer: Report From the Adelaide Colorectal Tumour Group Meeting; Stockholm, Sweden; September…
T. Price
,
N. Tebbutt
,
+6 authors
J. Shapiro
Clinical colorectal cancer
2010
Corpus ID: 35479858
The medical treatment of patients with metastatic colorectal cancer (mCRC) has evolved greatly in the past 10 years, involving…
Expand
Highly Cited
2007
Highly Cited
2007
Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma
K. Uka
,
H. Aikata
,
+7 authors
K. Chayama
Journal of gastroenterology
2007
Corpus ID: 7366009
BackgroundSeveral studies have reported survival benefits of combination therapy with intraarterial 5-fluorouracil (5-FU) and…
Expand
2004
2004
Strategy for the treatment of unresectable hepatoblastoma: neoadjuvant chemotherapy followed by delayed primary operation or liver transplantation.
H. Urata
,
H. Hori
,
K. Uchida
,
M. Inoue
,
Y. Komada
,
M. Kusunoki
International surgery
2004
Corpus ID: 7953066
We present our experience in using neoadjuvant regional and systemic chemotherapy together with surgical resection as a strategy…
Expand
2003
2003
[Dynamic magnetic resonance tomography (dMRT). It's value in advanced head-neck tumors treated with radiochemotherapy].
M. Helbig
,
H. Schlemmer
,
M. Lumer
,
M. Knopp
,
A. Dietz
HNO (Berlin. Print)
2003
Corpus ID: 21920772
PURPOSE With the help of dynamic magnetic resonance tomography (dMRT) the status of tissue microcirculation can be visualized…
Expand
2002
2002
Preoperative chemoembolization for unresectable hepatoblastoma
D. Tashjian
,
K. Moriarty
,
R. Courtney
,
M. Bean
,
D. A. Steele
Pediatric surgery international (Print)
2002
Corpus ID: 27853326
Abstract Complete surgical resection offers the only chance for cure in patients with hepatoblastoma (HB). Patients with…
Expand
1990
1990
Effects on interleukin 1 alpha and beta production of peripheral blood mononuclear cells from patients with hepatocellular carcinoma after transcatheter arterial embolization
M. Kanai
,
H. Kohda
,
C. Sekiya
,
M. Namiki
Gastroenterologia Japonica
1990
Corpus ID: 12362820
To clarify the immunological effects of transcatheter arterial embolization (TAE) therapy for hepatocellular carcinoma (HCC), we…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE